Nachrichten zur Novo-Nordisk AS Aktie

Novo Nordisk: Weiterhin beeindruckendes Wachstum - Aktienanalyse

Wien (www.aktiencheck.de) - Novo Nordisk-Aktienanalyse von der Raiffeisen Bank International AG: Raphael Schicho, Analyst der Raiffeisen Bank International AG (RBI), nimmt…

Novo Nordisk flags continued restrictions on Wegovy supplies By Reuters

Novo Nordisk flags continued restrictions on Wegovy supplies…

Novo Nordisks sales increased by 29% in Danish kroner and by 33% at constant exchange rates to DKK 166.4 billion in the first nine months of 2023

Bagsværd 2 November 2023 - Financial report for the period 1 January 2023 to 30 September 2023 …

Novo Nordisk (NVO) Q3 Earnings and Sales Beat, 2023 View Up

Novo Nordisk (NVO) reports encouraging third-quarter results, beating both earnings and sales estimates, driven by strong sales of diabetes and…

Novo Nordisk A/S - share repurchase programme

Bagsværd, Denmark, 1 November 2023 – On 10 August 2023, Novo Nordisk initiated a share repurchase programme in accordance with…

Shell, Apple, Novo Nordisk and Interest rates: Day ahead on Thursday

The Bank of Englands interest rate decision comes after a tight 5-4 vote last time, but the voting split is expected to…

Novo Nordisk: 1.550 oder 690 DKK? Kursziele und Ratings der Analysten vor Q3-Zahlen auf einen Blick - Aktiennews

Bagsværd (www.aktiencheck.de) - Welche Kursziele und Ratings trauen die Analysten der führenden Banken und Research-Häuser der Aktie des dänischen Pharmakonzerns…

Novo Nordisk (NVO) to Report Q3 Earnings: Whats in the Cards?

Novo Nordisk (NVO) is likely to outperform third-quarter 2023 estimates, driven by increased Diabetes and Obesity Care product sales despite…

Novo Nordisk: Markt für Krebsmedikamente - Der spannende Studienstart - Aktienanalyse

Kulmbach (www.aktiencheck.de) - Novo Nordisk-Aktienanalyse von "Der Aktionär": Michel Doepke vom Anlegermagazin "Der Aktionär" nimmt die Aktie von Novo Nordisk A/S…

Novo Nordisk: Spannender Studienstart

Europas wertvollstes börsennotiertes Unternehmen schwimmt dank dem Boom bei Diabetes- und Adipositas-Medikamenten auf der Erfolgswelle. Doch Novo Nordisk drängt unlängst…

Beat the Market the Zacks Way: Novo Nordisk, Lifeway Foods, Caseys in Focus

Our time-tested methodologies were at work to help investors navigate the market well last week. Here are some of our…

Novo Nordisk Just Consolidated Its Grip on Yet Another Market. Is It a Buy?

Novo Nordisk is planting the seeds to become a competitor in chronic kidney disease therapies.…

Here are 5 anti-obesity drug stocks besides Novo Nordisk and Eli Lilly to watch into year-end

Companies — both big and small — are hoping to grab a piece of the lucrative anti-obesity drug market. Piper…

Gefährdet Novo Nordisk die Dividende von Coca-Cola? [Video]

Die Dividende von Coca-Cola ist sicher, oder…?! Coca-Cola gilt als eine der defensivsten Dividendenaktien. Neuigkeiten rund um Novo Nordisk und…

Week ahead: Apple, Novo Nordisk, Pfizer, PayPay, Starbucks, AMD and more

Apple and Novo Nordisk (NYSE:NVO) are due to deliver earnings next week, along with Pfizer, Moderna, PayPal, Coinbase, Starbucks and many more. …

Week ahead: Apple, Novo Nordisk, Shell, BP, HSBC, GSK, plus Fed and BoE

Central banks and some giant companies results jostle for investor attention in the coming week, not to mention geopolitics, economic…

Orexo announces changes in the company´s Board of Directors

Uppsala, Sweden – October 27, 2023 – Orexo AB (publ.), (STO:ORX) (OTCQX:ORXOY), announces that Robin Evers, Senior Vice President, Head…

The Zacks Analyst Blog Highlights Microsoft, Novo Nordisk A/S and Lowes

Microsoft, Novo Nordisk A/S and Lowes are included in this Analyst Blog.…

How to Invest in Genetics (Updated 2023)

Genetics is the study of genes, their variations and hereditary characteristics, as well as how these traits are passed on…

1 Green Flag and 1 Red Flag for Novo Nordisk

Even this high-flying company has its detractors.…

Belgium mulls short-term ban on use of Novo Nordisk’s Ozempic for weight loss

…

Novo Nordisk: Growing To Potentially Become The First Trillion-Dollar European Champion

…

Novo Nordisk: Die Abnehm-Spritze bleibt ein Kurstreiber

Dr. Bernd Heim (Gurupress.de) - Die Aktie von Novo Nordisk bleibt einer der Topfavoriten in unserem Basis-Depot. Seit dem Kauf…

2 Stock-Split Stocks That Could Plunge Up to 89%, According to Select Wall Street Analysts @themotleyfool #stocks $TSLA $GOOGL $AMZN $NVDA $MNST $NVO $PANW $GOOG $SHOP $DXCM

Among Nvidia, Amazon, DexCom, Shopify, Alphabet, Tesla, Palo Alto Networks, Monster Beverage, and Novo Nordisk, there are two high-flying stock-split…

2 Stock-Split Stocks That Could Plunge Up to 89%, According to Select Wall Street Analysts

Among Nvidia, Amazon, DexCom, Shopify, Alphabet, Tesla, Palo Alto Networks, Monster Beverage, and Novo Nordisk, there are two high-flying stock-split…

Märkte am Morgen: DAX nach schwacher Vorwoche mit Erholungsversuch; Bitcoin, Tesla, Siemens Energy, Sartorius, Adidas, LVMH, Sartorius, Novo Nordisk im Fokus

Der DAX arbeitet am Montag an einer Stabilisierung und notiert 30 Minuten vor dem Xetra-Start 0,3 Prozent höher bei 14.848…

Analysis: Anti-obesity drugs can be boost for food makers, investors say

The growth in demand for appetite suppressing anti-obesity drugs like Novo Nordisks Wegovy presents opportunities for food manufacturers and the…

Analysis-Anti-Obesity Drugs Can Be Boost for Food Makers, Investors Say

By Richa Naidu and David Randall LONDON/NEW YORK (Reuters) - The growth in demand for appetite suppressing anti-obesity drugs like…

Novo Nordisk (NVO) Advances While Market Declines: Some Information for Investors

The latest trading day saw Novo Nordisk (NVO) settling at $97.12, representing a +0.86% change from its previous close.…

Take the Zacks Approach to Beat the Market: Novo Nordisk, Amgen, Fabrinet in Focus

Last week, our time-tested methodologies served investors well in navigating the market. Check out some of our achievements from the…

Perfekter Buy & Hold-Kandidat?: Novo Nordisk: Bullen setzen sich durch - Kursziel erhöht!

Jetzt neu – Optionsscheine auf Novo Nordisk ADRs

Werbung …

Sanofi to offer insulin product for $35 to all Americans through GoodRx

The effort comes after Sanofi, Eli Lilly and Novo Nordisk announced sweeping insulin price cuts earlier this year.…

1 Thing Youd Better Know Before You Invest in the Stocks Behind Ozempic and Mounjaro @themotleyfool #stocks $NVO $LLY

Eli Lilly and Novo Nordisk are both battling demand issues for flagship treatments.…

1 Thing Youd Better Know Before You Invest in the Stocks Behind Ozempic and Mounjaro

Eli Lilly and Novo Nordisk are both battling demand issues for flagship treatments.…

: GE HealthCare teams up with Novo Nordisk to treat diabetes without drugs

New ultrasound technology has potential to regulate metabolic function, early-stage clinical research shows…

Novo Nordisk: Kurszielsenkung

New York (www.aktiencheck.de) - Rating-Update: Seamus Fernandez, Analyst von Guggenheim Securities, stuft die Aktie von Novo Nordisk A/S (ISIN: DK0060534915, WKN:…

Together for CHANGE Genomics and Equity Initiative Launched by a Coalition of Meharry Medical College, Regeneron Genetics Center, AstraZeneca, Novo Nordisk, and Roche to Improve Health Outcomes for People of African Ancestry

NIH data show that globally less than 2% of genetic information being studied today originates from people of African ancestry1…

3 Stock-Split Stocks With 110% to 696% Upside, According to Select Wall Street Analysts and Pundits @themotleyfool #stocks $TSLA $NVDA $GOOGL $NVO $AMZN $MNST $PANW $DXCM $GOOG $SHOP

Among Nvidia, Amazon, DexCom, Shopify, Alphabet, Tesla, Palo Alto Networks, Monster Beverage, and Novo Nordisk, there are three stock-split stocks…

3 Stock-Split Stocks With 110% to 696% Upside, According to Select Wall Street Analysts and Pundits

Among Nvidia, Amazon, DexCom, Shopify, Alphabet, Tesla, Palo Alto Networks, Monster Beverage, and Novo Nordisk, there are three stock-split stocks…

Novo Nordisk: Kursziel gesteigert

New York (www.aktiencheck.de) - Rating-Update: Die Analysten der Citigroup bewerten von Novo Nordisk A/S (ISIN: DK0062498333, WKN: A3EU6F, Ticker-Symbol: NOV, NASDAQ…

Novo Nordisk: Kursziel angehoben

London (www.aktiencheck.de) - Rating-Update: Die Analysten von Barclays stufen die Aktie von Novo Nordisk A/S (ISIN: DK0062498333, WKN: A3EU6F, Ticker-Symbol: NOV,…

Nel ASA wagt sich aus der Deckung, TUI ringt um die Bodenbildung, Pfizer zieht den Sparstrumpf an und Novo Nordisk bleibt auf hohem Niveau

Die Märkte wurden in jüngster Zeit wieder einmal von vielen Sorgen und Nöten begleitet, was die Kurse vielerorts zuverlässig in…

dpa-AFX ProFeed